RhoA and NF-κB are involved in lipopolysaccharide-induced brain microvascular cell line hyperpermeability

Neuroscience

Volumn 188, Issue , 2011, Pages 35-47

  He, F ^a   Peng, J ^a   Deng, X L ^a   Yang, L F ^a   Wu, L W ^a   Zhang, C L ^a   Yin, F ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Brain microvascular endothelial cells; Lipopolysaccharide; NF B; Permeability; RhoA; Tight junction

Indexed keywords

F ACTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN ZO1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; BRAIN CELL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME ASSAY; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION; WESTERN BLOTTING;

ANIMALS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE PERMEABILITY; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 79958772442     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.04.025     Document Type: Article

References (62)

1. Afonso P.V., Ozden S., Prevost M.C., Schmitt C., Seilhean D., Weksler B., Couraud P.O., Gessain A., Romero I.A., Ceccaldi P.E. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol 2007, 179:2576-2583.
2. Al-Sadi R., Ye D., Dokladny K., Ma T.Y. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008, 180:5653-5661.
3. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., Abraham E. Involvement of reactive oxygen species in toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004, 172:2522-2529.
4. Banan A., Keshavarzian A., Zhang L., Shaikh M., Forsyth C.B., Tang Y., Fields J.Z. NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. Alcohol 2007, 41:447-460.
5. Banks W.A., Erickson M.A. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010, 37:26-32.
6. Birukova A.A., Smurova K., Birukov K.G., Kaibuchi K., Garcia J.G., Verin A.D. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004, 67:64-77.
7. Brown R.C., Morris A.P., O'Neil R.G. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res 2007, 1130:17-30.
8. Chakravortty D., Koide N., Kato Y., Sugiyama T., Kawai M., Fukada M., Yoshida T., Yokochi T. Cytoskeletal alterations in lipopolysaccharide-induced bovine vascular endothelial cell injury and its prevention by sodium arsenite. Clin Diagn Lab Immunol 2000, 7:218-225.
9. Chen Q., Gupta S., Pernis A.B. Regulation of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho GTPases. J Leukoc Biol 2009, 85:539-543.
10. Eiselein L., Wilson D.W., Lame M.W., Rutledge J.C. Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-actin, and induce apoptosis. Am J Physiol Heart Circ Physiol 2007, 292:H2745-H2753.
11. Fanning A.S., Ma T.Y., Anderson J.M. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J 2002, 16:1835-1837.
12. Fessler M.B., Arndt P.G., Just I., Nick J.A., Malcolm K.C., Worthen G.S. Dual role for RhoA in suppression and induction of cytokines in the human neutrophil. Blood 2007, 109:1248-1256.
13. Fischer S., Wobben M., Marti H.H., Renz D., Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 2002, 63:70-80.
14. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008, 130:55-70.
15. Goldblum S.E., Ding X., Brann T.W., Campbell-Washington J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J Cell Physiol 1993, 157:13-23.
16. Goto K., Chiba Y., Sakai H., Misawa M. Tumor necrosis factor-alpha (TNF-alpha) induces upregulation of RhoA via NF-kappaB activation in cultured human bronchial smooth muscle cells. J Pharmacol Sci 2009, 110:437-444.
17. Gutierrez-Venegas G., Contreras-Marmolejo L.A., Roman-Alvarez P., Barajas-Torres C. Aggregatibacter actinomycetemcomitans lipopolysaccharide affects human gingival fibroblast cytoskeletal organization. Cell Biol Int 2008, 32:417-426.
18. Hawkins B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005, 57:173-185.
19. He F., Yin F., Peng J., Li K.Z., Wu L.W., Deng X.L. Immortalized mouse brain endothelial cell line Bend.3 displays the comparative barrier characteristics as the primary brain microvascular endothelial cells. Zhongguo Dang Dai Er Ke Za Zhi 2010, 12:474-478.
20. Huang S., Chen L.Y., Zuraw B.L., Ye R.D., Pan Z.K. Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA. J Biol Chem 2001, 276:40977-40981.
21. Huang X., Chen L.Y., Doerner A.M., Pan W.W., Smith L., Huang S., Papadimos T.J., Pan Z.K. An atypical protein kinase C (PKC zeta) plays a critical role in lipopolysaccharide-activated NF-kappa B in human peripheral blood monocytes and macrophages. J Immunol 2009, 182:5810-5815.
22. Imler J.L., Zheng L. Biology of toll receptors: lessons from insects and mammals. J Leukoc Biol 2004, 75:18-26.
23. Kisseleva T., Song L., Vorontchikhina M., Feirt N., Kitajewski J., Schindler C. NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer. J Clin Invest 2006, 116:2955-2963.
24. Koedel U., Scheld W.M., et al. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002, 2(12):721-736.
25. Kuhlmann C.R., Tamaki R., Gamerdinger M., Lessmann V., Behl C., Kempski O.S., Luhmann H.J. Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption. J Neurochem 2007, 102:501-507.
26. Lai C.H., Kuo K.H., Leo J.M. Critical role of actin in modulating BBB permeability. Brain Res Brain Res Rev 2005, 50:7-13.
27. Laukoetter M.G., Bruewer M., Nusrat A. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol 2006, 22:85-89.
28. Leve F., de Souza W., Morgado-Diaz J.A. A cross-link between protein kinase A and Rho-family GTPases signaling mediates cell-cell adhesion and actin cytoskeleton organization in epithelial cancer cells. J Pharmacol Exp Ther 2008, 327:777-788.
29. Liebner S., Kniesel U., Kalbacher H., Wolburg H. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur J Cell Biol 2000, 79:707-717.
30. Liu L.B., Xue Y.X., Liu Y.H., Wang Y.B. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton. J Neurosci Res 2008, 86:1153-1168.
31. Liu S.F., Ye X., Malik A.B. Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 1999, 55:658-667.
32. Ma T.Y., Iwamoto G.K., Hoa N.T., Akotia V., Pedram A., Boivin M.A., Said H.M. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol 2004, 286:G367-G376.
33. Mark K.S., Davis T.P. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 2002, 282:H1485-H1494.
34. Mashukova A., Wald F.A., Salas P.J. Tumor necrosis factor alpha and inflammation disrupt the polarity complex in intestinal epithelial cells by a posttranslational mechanism. Mol Cell Biol 2011, 31:756-765.
35. Monick M.M., Powers L.S., Butler N.S., Hunninghake G.W. Inhibition of Rho family GTPases results in increased TNF-alpha production after lipopolysaccharide exposure. J Immunol 2003, 171:2625-2630.
36. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-660.
37. Polk W.W., Ellis M.E., Kushleika J.V., Simmonds P.L., Woods J.S. RhoA regulation of NF-kappaB activation is mediated by COX-2-dependent feedback inhibition of IKK in kidney epithelial cells. Am J Physiol Cell Physiol 2007, 293:C1160-C1170.
38. Qiu L.B., Ding G.R., Li K.C., Wang X.W., Zhou Y., Zhou Y.C., Li Y.R., Guo G.Z. The role of protein kinase C in the opening of blood-brain barrier induced by electromagnetic pulse. Toxicology 2010, 273:29-34.
39. Rattan R., Giri S., Singh A.K., Singh I. Rho A negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKalpha. Free Radic Biol Med 2003, 35:1037-1050.
40. Riganti C., Doublier S., Costamagna C., Aldieri E., Pescarmona G., Ghigo D., Bosia A. Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol Pharmacol 2008, 74:476-484.
41. Rosenberg G.A., Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus 2007, 22:E4.
42. Sandoval K.E., Witt K.A. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008, 32:200-219.
43. Shimizu S., Tahara M., Ogata S., Hashimoto K., Morishige K., Tasaka K., Murata Y. Involvement of nuclear factor-kB activation through RhoA/Rho-kinase pathway in LPS-induced IL-8 production in human cervical stromal cells. Mol Hum Reprod 2007, 13:181-187.
44. Singh A.K., Jiang Y., Gupta S. Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation. Toxicol Mech Methods 2007, 17:331-347.
45. Spindler V., Schlegel N., et al. Role of GTPases in control of microvascular permeability. Cardiovasc Res 2010, 87(2):243-253.
46. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., Andjelkovic A.V. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir Suppl 2006, 96:444-450.
47. Sumi N., Nishioku T., Takata F., Matsumoto J., Watanabe T., Shuto H., Yamauchi A., Dohgu S., Kataoka Y. Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia. Cell Mol Neurobiol 2010, 30:247-253.
48. Teusch N., Lombardo E., Eddleston J., Knaus U.G. The low molecular weight GTPase RhoA and atypical protein kinase Czeta are required for TLR2-mediated gene transcription. J Immunol 2004, 173:507-514.
49. Tiruppathi C., Shimizu J., Miyawaki-Shimizu K., Vogel S.M., Bair A.M., Minshall R.D., Predescu D., Malik A.B. Role of NF-kappaB-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide. J Biol Chem 2008, 283:4210-4218.
50. Van Itallie C.M., Fanning A.S., Bridges A., Anderson J.M. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 2009, 20:3930-3940.
51. Vandenbroucke E., Mehta D., Minshall R., Malik A.B. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008, 1123:134-145.
52. Verin A.D., Birukova A., Wang P., Liu F., Becker P., Birukov K., Garcia J.G. Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 2001, 281:L565-L574.
53. Verstrepen L., Bekaert T., Chau T.L., Tavernier J., Chariot A., Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 2008, 65:2964-2978.
54. Wachtel M., Bolliger M.F., Ishihara H., Frei K., Bluethmann H., Gloor S.M. Down-regulation of occludin expression in astrocytes by tumour necrosis factor (TNF) is mediated via TNF type-1 receptor and nuclear factor-kappaB activation. J Neurochem 2001, 78:155-162.
55. Wu X., Guo R., Chen P., Wang Q., Cunningham P.N. TNF induces caspase-dependent inflammation in renal endothelial cells through a Rho- and myosin light chain kinase-dependent mechanism. Am J Physiol Renal Physiol 2009, 297:F316-F326.
56. Xaio H., Banks W.A., Niehoff M.L., Morley J.E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Res 2001, 896:36-42.
57. Yamamoto M., Ramirez S.H., Sato S., Kiyota T., Cerny R.L., Kaibuchi K., Persidsky Y., Ikezu T. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am J Pathol 2008, 172:521-533.
58. Ye D., Ma I., Ma T.Y. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 2006, 290:G496-G504.
59. Ye D., Ma T.Y. Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-alpha-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med 2008, 12:1331-1346.
60. Yokoyama S., Tachibana K., Nakanishi H., Yamamoto Y., Irie K., Mandai K., Nagafuchi A., Monden M., Takai Y. Alpha-catenin-independent recruitment of ZO-1 to nectin-based cell-cell adhesion sites through afadin. Mol Biol Cell 2001, 12:1595-1609.
61. Youakim A., Ahdieh M. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999, 276:G1279-G1288.
62. Yu D., Marchiando A.M., Weber C.R., Raleigh D.R., Wang Y., Shen L., Turner J.R. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci U S A 2010, 107:8237-8241.